Clinical Trial

The Effects of Pancreatic Enzyme Supplementation in Critically Ill Patients on Enteral Feeding

Study acronym: PREZENT
Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated November 8, 2021 (before its estimated July 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
Determine the effect of high-dose pancreatic enzyme supplementation on nutritional indicators and clinical course in critically ill patients undergoing enteral nutrition.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-09
Trial Details
NCT Number NCT05112328
Lead Sponsor Seoul National University Hospital
Conditions Critically Ill, Enteral Feeding, Exocrine Pancreatic Insufficiency
Enrollment 170 participants
Start Date 2021-07-07
Primary Completion 2026-07-31 (estimated)
Study Completion 2026-07-31 (estimated)
Updated on ClinicalTrials.gov 2021-11-08